自身免疫疾病治疗新希望：CAR T细胞疗法

New therapies based on a revolutionary cancer treatment could be approved as early as next year, finds Michael Le Page OUR immune systems never stop targeting cells they regard as a threat, so it’s bad news when rogue immune cells turn on us, as they do in autoimmune conditions. Existing treatments suppress, but don’t stop, these attacks. But an approach that addresses the cause of these disorders by killing off the rogue cells is proving wildly successful. The key is genetically engineered cells known as CAR T-cells. These are made from the T-cells your immune system usually employs to kill off invasive bacteria or virus-infected cells. …